Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug

Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer's drug experienced brain bleeding or swelling, though many cases were asymptomatic.

Read at Nytimes